Search results for "ovarian failure"

showing 3 items of 13 documents

[Contraception in chronically ill adolescents].

2003

Contraception in chronically ill adolescents has to consider side effects with regard to metabolic or hematological disease. Additionally the compliance of the patient has to be taken in account when consulting about contraceptives. In juvenile diabetics with good glycemic control and metabolic diseases of the amino acids oral contraceptives are justifiable. Adolescents with galactose-mia mostly suffer from premature ovarian failure and therefore have to be controlled wether they need contraception at all. Young women with sickle-cell anemia are at risk of thrombophilia. They should not be given hormonal contraceptives. In v. Willebrand-Jurgens-Syndrome oral contraceptives are favourable be…

Malemedicine.medical_specialtyPediatricsAdolescentAnemiaSexual BehaviorDiseaseThrombophiliaDiabetes mellitusmedicineHumansGlycemicGynecologybusiness.industryContraindicationsObstetrics and Gynecologymedicine.diseasePremature ovarian failureChronic diseaseContraceptionDiabetes Mellitus Type 1Sexual behaviorChronic DiseaseFemalebusinessSexualityContraceptives OralZentralblatt fur Gynakologie
researchProduct

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.

2003

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in 30 women with idiopathic premature ovarian failure (POF), 30 postmenopausal women, and 30 age-matched fertile women were determined. Women with POF showed low levels of inhibin A and inhibin B, but not of activin A, whereas the levels of pro-alphaC were significantly higher than in postmenopausal women. Thus, the circulating level of pro-alphaC could be a marker for assessing residual ovarian function in women with POF.

endocrine systemInhibin amedicine.medical_specialtyendocrine system diseasesPrimary Ovarian InsufficiencyAndrologyOvarian functionInternal medicineMedicineHumansInhibinsProtein Precursorsreproductive and urinary physiologyInhibin bPostmenopausal womenbusiness.industryObstetrics and Gynecologyfemale genital diseases and pregnancy complicationsActivin aPostmenopauseIdiopathic premature ovarian failureEndocrinologyReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength.

2019

Skeletal muscle weakness occurs with aging and in females this is compounded by the loss of estrogen with ovarian failure. Estrogen deficiency mediates decrements in muscle strength from both inadequate preservation of skeletal muscle mass and decrements in the quality of the remaining skeletal muscle. Processes and components of skeletal muscle that are affected by estrogens are beginning to be identified. This review focuses on mechanisms that contribute to the loss of muscle force generation when estrogen is low in females, and conversely the maintenance of strength by estrogen. Evidence is accumulating that estrogen deficiency induces apoptosis in skeletal muscle contributing to loss of…

estrogeenit0301 basic medicinemedicine.medical_specialtyAgingProteasome Endopeptidase ComplexHistologyPhysiologymedicine.drug_classEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismApoptosisArticle03 medical and health sciences0302 clinical medicineInternal medicineestrogenmedicineHumansMuscle Strengthskeletal muscleta315Muscle SkeletalMuscle forcebusiness.industryagingOvarian failureUbiquitinationSkeletal muscleta3141Estrogensmedicine.diseaseGenerating capacityikääntyminen030104 developmental biologymedicine.anatomical_structureEndocrinologyEstrogenSarcopeniaMuscle strengthEstrogenic EffectsFemalestrengthbusinesshormones hormone substitutes and hormone antagonistslihasvoimaBone
researchProduct